Literature DB >> 23046018

Genetic counseling in melanoma.

Celia Badenas1, Paula Aguilera, Joan A Puig-Butillé, Cristina Carrera, Josep Malvehy, Susana Puig.   

Abstract

Genetic counseling may be offered to families with melanoma and to individuals with multiple melanomas to better understand the genetic susceptibility of the disease, the influence of environmental factors, the inheritance of the risk, and behavior that decreases the risk of dying from melanoma, including specific dermatological follow-up such as total body photography and digital dermoscopy. Genetic testing may be offered to those individuals with more than a 10% chance of being a carrier of a mutation. This risk varies according to the incidence of melanoma in the country and sun behavior. In countries with a low-medium incidence of melanoma, genetic testing should be offered to families with two cases of melanoma or an individual with two primary melanomas. In countries with a high incidence, families with three cases of melanoma, with two melanomas and one pancreatic adenocarcinoma, or patients with three primary melanomas, may benefit from genetic testing.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23046018      PMCID: PMC3470473          DOI: 10.1111/j.1529-8019.2012.01499.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  46 in total

1.  An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele.

Authors:  Chandra G Bertram; Rupert M Gaut; Jennifer H Barrett; Elizabeth Pinney; Linda Whitaker; Faye Turner; Veronique Bataille; Isabel Dos Santos Silva; Anthony J Swerdlow; D Timothy Bishop; Julia A Newton Bishop
Journal:  J Invest Dermatol       Date:  2002-10       Impact factor: 8.551

2.  Germline p16 mutations in familial melanoma.

Authors:  C J Hussussian; J P Struewing; A M Goldstein; P A Higgins; D S Ally; M D Sheahan; W H Clark; M A Tucker; N C Dracopoli
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

3.  Hereditary cutaneous malignant melanoma: a 20-year family update.

Authors:  D E Anderson; M D Badzioch
Journal:  Anticancer Res       Date:  1991 Jan-Feb       Impact factor: 2.480

4.  Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.

Authors:  H Tsao; X Zhang; K Kwitkiwski; D M Finkelstein; A J Sober; F G Haluska
Journal:  Arch Dermatol       Date:  2000-09

5.  Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.

Authors:  Colin B Begg; Irene Orlow; Amanda J Hummer; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Robert C Millikan; Stephen B Gruber; Hoda Anton-Culver; Roberto Zanetti; Richard P Gallagher; Terence Dwyer; Timothy R Rebbeck; Nandita Mitra; Klaus Busam; Lynn From; Marianne Berwick
Journal:  J Natl Cancer Inst       Date:  2005-10-19       Impact factor: 13.506

6.  Geographical variation in the penetrance of CDKN2A mutations for melanoma.

Authors:  D Timothy Bishop; Florence Demenais; Alisa M Goldstein; Wilma Bergman; Julia Newton Bishop; Brigitte Bressac-de Paillerets; Agnès Chompret; Paola Ghiorzo; Nelleke Gruis; Johan Hansson; Mark Harland; Nicholas Hayward; Elizabeth A Holland; Graham J Mann; Michela Mantelli; Derek Nancarrow; Anton Platz; Margaret A Tucker
Journal:  J Natl Cancer Inst       Date:  2002-06-19       Impact factor: 13.506

7.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Authors:  M Serrano; G J Hannon; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

8.  Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma.

Authors:  Paolo Carli; Vincenzo De Giorgi; Domenico Palli; Andrea Maurichi; Patrizio Mulas; Catiuscia Orlandi; Gian Lorenzo Imberti; Ignazio Stanganelli; Pierfranco Soma; Domenico Dioguardi; Caterina Catricalá; Roberto Betti; Roberto Cecchi; Ugo Bottoni; Angela Bonci; Massimiliano Scalvenzi; Benvenuto Giannotti
Journal:  Arch Dermatol       Date:  2003-05

Review 9.  Clinical germline genetic testing for melanoma.

Authors:  Christopher B Hansen; Lisa M Wadge; Katrina Lowstuter; Kenneth Boucher; Sancy A Leachman
Journal:  Lancet Oncol       Date:  2004-05       Impact factor: 41.316

10.  Pancreatic carcinoma surveillance in patients with familial melanoma.

Authors:  Jana Foley Parker; Scott R Florell; April Alexander; James A DiSario; Paul J Shami; Sancy A Leachman
Journal:  Arch Dermatol       Date:  2003-08
View more
  11 in total

1.  Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.

Authors:  Miriam Potrony; Joan Anton Puig-Butillé; Paula Aguilera; Celia Badenas; Cristina Carrera; Josep Malvehy; Susana Puig
Journal:  J Am Acad Dermatol       Date:  2014-07-24       Impact factor: 11.527

Review 2.  Progress report on the major clinical advances in patient-oriented research into familial melanoma (2013-2018).

Authors:  Mijke Visser; Nienke van der Stoep; Nelleke Gruis
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

Review 3.  Barriers to risk-understanding and risk-reduction behaviors among individuals with a family history of melanoma.

Authors:  Laura Fitzpatrick; Jennifer L Hay
Journal:  Melanoma Manag       Date:  2014-12-04

Review 4.  Update in genetic susceptibility in melanoma.

Authors:  Miriam Potrony; Celia Badenas; Paula Aguilera; Joan Anton Puig-Butille; Cristina Carrera; Josep Malvehy; Susana Puig
Journal:  Ann Transl Med       Date:  2015-09

5.  Genome-wide linkage analysis in Spanish melanoma-prone families identifies a new familial melanoma susceptibility locus at 11q.

Authors:  Miriam Potrony; Joan Anton Puig-Butille; James M Farnham; Pol Giménez-Xavier; Celia Badenas; Gemma Tell-Martí; Paula Aguilera; Cristina Carrera; Josep Malvehy; Craig C Teerlink; Susana Puig
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

6.  Identifying gene-gene interactions using penalized tensor regression.

Authors:  Mengyun Wu; Jian Huang; Shuangge Ma
Journal:  Stat Med       Date:  2017-10-16       Impact factor: 2.373

Review 7.  Germline mutations predisposing to melanoma.

Authors:  Atrin Toussi; Nicole Mans; Jeanna Welborn; Maija Kiuru
Journal:  J Cutan Pathol       Date:  2020-05-11       Impact factor: 1.587

8.  Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study.

Authors:  Iván Márquez-Rodas; Manuel Martín González; Eduardo Nagore; Cristina Gómez-Fernández; Jose Antonio Avilés-Izquierdo; Cayetana Maldonado-Seral; Virtudes Soriano; Margarita Majem-Tarruella; Virginia Palomar; Rocio Maseda; Alfonso Martín-Carnicero; Teresa Puertolas; Elena Godoy; Pablo Cerezuela; Maria Ochoa de Olza; Begoña Campos; Elisabeth Perez-Ruiz; Ainara Soria; Irene Gil-Arnaiz; Maria Gonzalez-Cao; Elisa Galvez; Ana Arance; Joaquin Belon; Luis de la Cruz-Merino; Salvador Martín-Algarra
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

9.  Relationship Between LAPTM4B Gene Polymorphism and Susceptibility of Malignant Melanoma in Chinese Patients.

Authors:  Meng Zhang; Rouli Zhou; Jianjun Xu; Qingyun Zhang
Journal:  Transl Oncol       Date:  2014-10-24       Impact factor: 4.243

10.  Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma.

Authors:  Susana Puig; Miriam Potrony; Francisco Cuellar; Joan Anton Puig-Butille; Cristina Carrera; Paula Aguilera; Eduardo Nagore; Zaida Garcia-Casado; Celia Requena; Rajiv Kumar; Gilles Landman; Bianca Costa Soares de Sá; Gisele Gargantini Rezze; Luciana Facure; Alexandre Leon Ribeiro de Avila; Maria Isabel Achatz; Dirce Maria Carraro; João Pedreira Duprat Neto; Thais C Grazziotin; Renan R Bonamigo; Maria Carolina W Rey; Claudia Balestrini; Enrique Morales; Montserrat Molgo; Renato Marchiori Bakos; Patricia Ashton-Prolla; Roberto Giugliani; Alejandra Larre Borges; Virginia Barquet; Javiera Pérez; Miguel Martínez; Horacio Cabo; Emilia Cohen Sabban; Clara Latorre; Blanca Carlos-Ortega; Julio C Salas-Alanis; Roger Gonzalez; Zulema Olazaran; Josep Malvehy; Celia Badenas
Journal:  Genet Med       Date:  2015-12-17       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.